Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bergman

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
The Veterinary Record|April 15, 2005
Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hoursT Gore, M Headley, R Laris, et al.
Psychological Services|February 12, 2019
Therapeutic alliance across trauma-focused and non-trauma-focused psychotherapies among veterans with PTSDJessica A Chen, John C Fortney, Hannah E Bergman, et al.
Analytical Chemistry|June 10, 2024
Ion Mobility-Mass Spectrometry and Collision-Induced Unfolding Rapidly Characterize the Structural Polydispersity and Stability of an Fc-Fusion ProteinRosendo C Villafuerte-Vega, Henry W Li, Addison E Bergman, et al.
The Veterinary Record|July 5, 2005
Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccineA A C Jacobs, R P H Theelen, R Jaspers, et al.
The Veterinary Record|January 16, 2007
Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2A A C Jacobs, J G H E Bergman, R P H Theelen, et al.
The Laryngoscope|September 3, 2017
Sinonasal quality of life after endoscopic resection of malignant sinonasal and skull base tumorsJordan T Glicksman, Arjun K Parasher, Steven G Brooks, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Neurology|April 24, 2002
Dyslexia-specific brain activation profile becomes normal following successful remedial trainingP G Simos, J M Fletcher, E Bergman, et al.
Emerging Infectious Diseases|November 25, 2014
Accuracy of herdsmen reporting versus serologic testing for estimating foot-and-mouth disease prevalenceKenton L Morgan, Ian G Handel, Vincent N Tanya, et al.
Organic & Biomolecular Chemistry|January 19, 2012
Conformational stability studies of a stapled hexa-β3-peptide libraryRomila D Gopalan, Mark P Del Borgo, Ylva E Bergman, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
The Veterinary Record|April 15, 2005
Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hoursT Gore, M Headley, R Laris, et al.
Psychological Services|February 12, 2019
Therapeutic alliance across trauma-focused and non-trauma-focused psychotherapies among veterans with PTSDJessica A Chen, John C Fortney, Hannah E Bergman, et al.
Analytical Chemistry|June 10, 2024
Ion Mobility-Mass Spectrometry and Collision-Induced Unfolding Rapidly Characterize the Structural Polydispersity and Stability of an Fc-Fusion ProteinRosendo C Villafuerte-Vega, Henry W Li, Addison E Bergman, et al.
The Veterinary Record|July 5, 2005
Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccineA A C Jacobs, R P H Theelen, R Jaspers, et al.
The Veterinary Record|January 16, 2007
Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2A A C Jacobs, J G H E Bergman, R P H Theelen, et al.
The Laryngoscope|September 3, 2017
Sinonasal quality of life after endoscopic resection of malignant sinonasal and skull base tumorsJordan T Glicksman, Arjun K Parasher, Steven G Brooks, et al.
Lancet (London, England)|September 18, 1993
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusS V Seremetis, L M Aledort, G E Bergman, et al.
Neurology|April 24, 2002
Dyslexia-specific brain activation profile becomes normal following successful remedial trainingP G Simos, J M Fletcher, E Bergman, et al.
Emerging Infectious Diseases|November 25, 2014
Accuracy of herdsmen reporting versus serologic testing for estimating foot-and-mouth disease prevalenceKenton L Morgan, Ian G Handel, Vincent N Tanya, et al.
Organic & Biomolecular Chemistry|January 19, 2012
Conformational stability studies of a stapled hexa-β3-peptide libraryRomila D Gopalan, Mark P Del Borgo, Ylva E Bergman, et al.
Pageof 17